Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
18:11:16 EDT Fri 26 Apr 2024
Enter Symbol
or Name
USA
CA



Q:ACRX - ACELRX PHARMACEUTICALS INC - http://www.acelrx.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
ACRX - QDEFUNCT0.86    2.78  0.425Jan 09Jan 0915 min RT 2¢

Recent Trades - All 0 today
Time ETExPriceChangeVolume
     
     
     
     
     
     
     
     
     
     

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2024-01-09 09:05U:ACRXNews ReleaseAcelRx Announces Rebranding With Name Change to Talphera, Inc.
2023-12-12 08:30U:ACRXNews ReleaseAcelRx Pharmaceuticals Announces Publication of Study Evaluating Anticoagulation Practices for Continuous Renal Replacement Therapy in the United States
2023-11-08 16:05U:ACRXNews ReleaseAcelRx Reports Third Quarter 2023 Financial Results and Provides Corporate Update
2023-11-07 16:05U:ACRXNews ReleaseAcelRx to Host KOL Panel Discussion on Current Anticoagulant Use in Dialysis and the Upcoming Niyad ¢ „ ¢ Clinical Study
2023-10-26 16:30U:ACRXNews ReleaseAcelRx to Host Third Quarter 2023 Financial Results Call and Webcast on November 8, 2023
2023-10-03 08:30U:ACRXNews ReleaseAcelRx Receives IDE Approval for Niyad and Advances to a Single Registration Study
2023-09-06 08:30U:ACRXNews ReleaseAcelRx Pharmaceuticals to Participate in the H.C. Wainwright Annual Investment Conference
2023-08-10 16:05U:ACRXNews ReleaseAcelRx Reports Second Quarter 2023 Financial Results and Provides Corporate Update
2023-07-27 16:05U:ACRXNews ReleaseAcelRx to Host Second Quarter 2023 Financial Results Call and Webcast on August 10, 2023
2023-07-21 08:00U:ACRXNews ReleaseAcelRx Pharmaceuticals Announces Closing of Previously Announced Private Placement Priced At-The-Market Under Nasdaq Rules
2023-07-18 08:00U:ACRXNews ReleaseAcelRx Pharmaceuticals Announces $10 Million Private Placement of Securities Priced At-The-Market Under Nasdaq Rules
2023-05-10 16:05U:ACRXNews ReleaseAcelRx Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate Update